Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. NovoCure Limited
  6. News
  7. Analyst Reco.
    NVCR   JE00BYSS4X48

NOVOCURE LIMITED

(NVCR)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
73.30 USD   +5.47%
07/01Novocure to Report Second Quarter 2022 Financial Results
BU
06/24NOVOCURE LIMITED(NASDAQGS : NVCR) added to Russell 2500 Index
CI
06/24NOVOCURE LIMITED(NASDAQGS : NVCR) added to Russell 2500 Growth Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on NOVOCURE LIMITED
06/06HC Wainwright Initiates NovoCure at Buy, Sets Price Target at $115
MT
05/16HC Wainwright Initiates NovoCure at Buy With $115 Price Target
MT
05/13Piper Sandler Adjusts NovoCure's Price Target to $100 From $125, Reiterates Overweight ..
MT
04/04Evercore ISI Adjusts Price Target for NovoCure to $82 From $62, Maintains In-Line Ratin..
MT
02/08Loop Capital Starts NovoCure at Buy With $200 Price Target
MT
02/02Oppenheimer Upgrades NovoCure to Outperform From Perform; Price Target is $98
MT
01/20Truist Securities Upgrades NovoCure to Buy from Hold, Keeps $125 Price Target
MT
01/11Wells Fargo Adjusts NovoCure's Price Target to $70 From $105, Keeps Equalweight Rating
MT
01/10Wedbush Cuts NovoCure's Price Target to $45 From $85, Says 'Revenues Have Flat-Lined;' ..
MT
01/06Piper Sandler Adjusts NovoCure's Price Target to $130 From $180, Reiterates Overweight ..
MT
01/03Evercore ISI Upgrades NovoCure to In-Line From Underperform; Keeps Price Target at $82
MT
2021Wedbush Adjusts Price Target for NovoCure to $85 From $101, Maintains Underperform Rati..
MT
2021NOVOCURE : Wedbush Adjusts NovoCure PT to $101 From $148, Maintains Underperform Rating
MT
2021NOVOCURE : Wells Fargo Adjusts Price Target on NovoCure to $180 From $215, Maintains Equal..
MT
2021NOVOCURE : Mizuho Securities Adjusts NovoCure's Price Target to $200 From $229, Maintains ..
MT
2021NOVOCURE : Piper Sandler Adjusts NovoCure's Price Target to $240 From $235, Reiterates Ove..
MT
2021NOVOCURE : Mizuho Securities Cuts NovoCure to Neutral From Buy, Price Target to $229 From ..
MT
2021NOVOCURE : Wedbush Lowers NovoCure's Price Target to $148 From $154 on Optune Revenue Expe..
MT
2021NOVOCURE : Truist Securities Adjusts Price Target on NovoCure to $142 From $132, Maintains..
MT
2021NOVOCURE : JP Morgan Adjusts NovoCure PT to $172 From $103, Maintains Neutral Rating
MT
2021NOVOCURE : Northland Capital Adjusts NovoCure's Price Target to $250 from $200, Keeps Outp..
MT
2021NOVOCURE : Mizuho Adjusts NovoCure's Price Target to $242 From $175, Maintains Buy Rating
MT
2021NOVOCURE : Wedbush Cuts NovoCure to Underperform From Neutral, PT to $154 From $159 on Ass..
MT
2021NOVOCURE : Wells Fargo Adjusts NovoCure PT to $215 From $135, Maintains Equal Weight Ratin..
MT
2021NOVOCURE : Mizuho Adjusts Price Target on NovoCure to $175 From $150, Maintains Buy Rating
MT
2021NOVOCURE : Wedbush Adjusts NovoCure's Price Target to $159 From $110, Maintains Neutral Ra..
MT
Upcoming event on NOVOCURE LIMITED
07/28/22Interim 2022 Earnings Call
Upcoming sector events
07/19/22GETINGE AB : Interim 2022 Earnings Release
07/26/22MASIMO CORPORATION : Interim 2022 Earnings Release (Projected)
08/04/22IRAY TECHNOLOGY COMPANY LIMITED : Interim 2022 Earnings Release (Projected)
Sector
Healthcare
Healthcare Services
 Healthcare Equipment & Supplies
  Medical Equipment, Supplies & Distribution
   Medical Equipment